MRC1 and colorectal carcinoma: The results of immune staining indicated that the amount of CD4 + and CD8 + T cells increased in the OICR-9429-treated CRC tissues, as well as the NK cells labelled by NKp46, while CD206-labelled M2 macrophage decreased (Fig. 7E-J).